New gene therapy reverses heart failure in large animal model
A new gene therapy can reverse the effects of heart failure and restore cardiac function in a large animal model.… Read More »New gene therapy reverses heart failure in large animal model
A new gene therapy can reverse the effects of heart failure and restore cardiac function in a large animal model.… Read More »New gene therapy reverses heart failure in large animal model
New research from Karolinska Institutet shows that long-term treatment with sex hormones in transgender people can lead to significant changes… Read More »Hormone therapy affects metabolic health of transgender people, study finds
Duke-NUS Medical School scientists and collaborators have identified an inherited genetic variation prevalent among East Asians that contributes to drug… Read More »Groundbreaking research unlocks precision therapy for drug-resistant leukemia
While many people believe that poor sleep during pregnancy is inevitable, new research has found that cognitive behavioral therapy for… Read More »Sleep for 2: Insomnia therapy reduces postpartum depression, study says
Adults with hemophilia B saw their number of bleeding episodes decrease by an average of 71 percent after a single… Read More »Single-dose gene therapy has the potential to change the lives of adults with hemophilia B
Cognitive behavioral therapy, one of the most common treatments for depression, can teach coping skills, reinforce healthy behaviors, and counteract… Read More »Cognitive behavioral therapy improves brain circuits to alleviate depression
Cardiovascular safety of stopping beta-blocker treatment compared with continuing it in patients with a history of myocardial infarction (MI) could… Read More »Is long-term beta-blocker therapy necessary after a heart attack?
Gene therapy could cure genetic diseases, but it remains a challenge to package and deliver new genes to specific cells… Read More »Machine learning approach helps researchers design better gene delivery vehicles for gene therapy
The recent approval by the U.S. Food and Drug Administration of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for… Read More »Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment
Researchers at the University of California, San Diego, have discovered that the most common form of liver cancer (with a… Read More »Stem cell-derived therapy shows promise against treatment-resistant liver cancer